| Name | Title | Contact Details |
|---|
CarePoint Partners is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Claremont Partners is a Alameda, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
WHC is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Edmund Optics (EO) has been a leading supplier of precision optics and optical components since 1942, designing and manufacturing a wide array of multi-element optical lenses, lens coatings, imaging systems, and optomechanical equipment. Led by a staff of skilled optical engineers and scientists, EO is application focused and pursues new ways to implement optical technology, enabling advancements in industrial metrology, semiconductor manufacturing, life sciences, and more. EO is a worldwide presence in industrial optics extending well beyond our original manufacturing plant and corporate headquarters in Barrington, New Jersey, USA.
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.